| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 26,764 | $55,669 | $2.08 | 13 Jun 2024 | Direct |
| Graphite Bio, Inc. | Director | Stock Option (right to buy) | 20,000 | 19 Jul 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 20:15 |
| LENZ | Graphite Bio, Inc. | 19 Jul 2023 | 1 | $0 | 4 | Director | 21 Jul 2023, 17:01 |
| PLRX | PLIANT THERAPEUTICS, INC. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 17:26 |
| LENZ | Graphite Bio, Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 17:35 |
| PLRX | PLIANT THERAPEUTICS, INC. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 16:14 |
| PLRX | PLIANT THERAPEUTICS, INC. | 29 Jun 2021 | 1 | $0 | 4 | Director | 30 Jun 2021, 20:54 |
| LENZ | Graphite Bio, Inc. | 24 Jun 2021 | 0 | $0 | 3 | Director | 24 Jun 2021, 21:20 |
| LENZ | Graphite Bio, Inc. | 15 Apr 2021 | 2 | +$99,994 | 4 | Director | 01 Jul 2021, 19:00 |